PNC Financial Services Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.6K Buy
2,377
+757
+47% +$31.9K ﹤0.01% 3104
2026
Q1
$89.6K Buy
1,620
+60
+4% +$2.86K ﹤0.01% 2886
2025
Q4
$58.3K Sell
1,560
-121
-7% -$4.92K ﹤0.01% 3122
2025
Q3
$68K Buy
1,681
+93
+6% +$3.07K ﹤0.01% 3031
2025
Q2
$40.6K Sell
1,588
-83
-5% -$1.81K ﹤0.01% 3226
2025
Q1
$35.7K Buy
1,671
+97
+6% +$2.17K ﹤0.01% 3273
2024
Q4
$33.1K Buy
1,574
+107
+7% +$2.48K ﹤0.01% 3315
2024
Q3
$33K Buy
1,467
+180
+14% +$3.48K ﹤0.01% 3286
2024
Q2
$21.6K Buy
1,287
+34
+3% +$546 ﹤0.01% 3445
2024
Q1
$16.2K Buy
1,253
+293
+31% +$3.51K ﹤0.01% 3553
2023
Q4
$11.1K Sell
960
-1,327
-58% -$15K ﹤0.01% 3691
2023
Q3
$29.2K Sell
2,287
-763
-25% -$10.8K ﹤0.01% 3223
2023
Q2
$41.8K Buy
3,050
+764
+33% +$10.9K ﹤0.01% 3169
2023
Q1
$35K Sell
2,286
-192
-8% -$2.93K ﹤0.01% 3182
2022
Q4
$33.2K Buy
2,478
+1,188
+92% +$15.9K ﹤0.01% 3212
2022
Q3
$18K Buy
1,290
+506
+65% +$8.74K ﹤0.01% 3497
2022
Q2
$16K Sell
784
-7
-0.9% -$133 ﹤0.01% 3602
2022
Q1
$17K Buy
791
+22
+3% +$444 ﹤0.01% 3652
2021
Q4
$17K Sell
769
-97
-11% -$2.07K ﹤0.01% 3613
2021
Q3
$19K Sell
866
-33
-4% -$794 ﹤0.01% 3526
2021
Q2
$26K Sell
899
-28
-3% -$757 ﹤0.01% 3364
2021
Q1
$24K Buy
927
+119
+15% +$2.69K ﹤0.01% 3342
2020
Q4
$16K Buy
808
+169
+26% +$3.11K ﹤0.01% 3427
2020
Q3
$11K Sell
639
-823
-56% -$17.6K ﹤0.01% 3470
2020
Q2
$38K Sell
1,462
-886
-38% -$22K ﹤0.01% 2903
2020
Q1
$57K Buy
2,348
+840
+56% +$20.5K ﹤0.01% 2549
2019
Q4
$38K Buy
1,508
+826
+121% +$19.2K ﹤0.01% 3051
2019
Q3
$14K Sell
682
-237
-26% -$6.49K ﹤0.01% 3467
2019
Q2
$29K Sell
919
-256
-22% -$8.03K ﹤0.01% 3201
2019
Q1
$39K Buy
1,175
+77
+7% +$2.4K ﹤0.01% 3078
2018
Q4
$35K Buy
1,098
+42
+4% +$1.58K ﹤0.01% 3055
2018
Q3
$46K Buy
1,056
+12
+1% +$567 ﹤0.01% 3043
2018
Q2
$49K Buy
1,044
+501
+92% +$22.2K ﹤0.01% 2988
2018
Q1
$21K Buy
543
+72
+15% +$2.67K ﹤0.01% 3415
2017
Q4
$15K Buy
471
+309
+191% +$11K ﹤0.01% 3532
2017
Q3
$6K Buy
162
+9
+6% +$338 ﹤0.01% 3821
2017
Q2
$6K Buy
153
+56
+58% +$1.83K ﹤0.01% 3754
2017
Q1
$3K Buy
97
+89
+1,113% +$2.51K ﹤0.01% 3870
2016
Q4
$0 Buy
+8
New +$218 ﹤0.01% 4063
2016
Q3
Sell
-62
Closed -$1K 4199
2016
Q2
$1K Sell
62
-63
-50% -$1.31K ﹤0.01% 4364
2016
Q1
$3K Buy
125
+23
+23% +$659 ﹤0.01% 4062
2015
Q4
$3K Hold
102
﹤0.01% 4051
2015
Q3
$3K Buy
102
+3
+3% +$110 ﹤0.01% 4160
2015
Q2
$4K Buy
99
+38
+62% +$1.31K ﹤0.01% 4177
2015
Q1
$2K Hold
61
﹤0.01% 4315
2014
Q4
$2K Buy
+61
New +$1.69K ﹤0.01% 3813

Other funds holding PAHC

PNC Financial Services Group's PAHC Position: Q2 2026 in Review

PNC Financial Services Group increased its Phibro Animal Health (PAHC) stake by 47% in Q2 2026, buying an estimated $31.9K and bringing the position to 2,377 shares worth $74.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3104.

PNC Financial Services Group first reported a position in PAHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $89.6K in Q1 2026. 78 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • PNC Financial Services Group held 2,377 shares of Phibro Animal Health worth $74.6K as of Q2 2026.
  • PNC Financial Services Group bought 757 Phibro Animal Health shares in Q2 2026, an estimated $31.9K.
  • Phibro Animal Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3104 holding.
  • PNC Financial Services Group first reported a position in Phibro Animal Health in Q4 2014 and has held it in 46 quarters since.
  • PNC Financial Services Group's Phibro Animal Health position peaked at $89.6K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.